BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7773149)

  • 1. Comparative analysis of cytokines released by bone marrow stromal cells from normal donors and B-cell chronic lymphocytic leukemic patients.
    Lagneaux L; Delforge A; Bron D; Bosmans E; Stryckmans P
    Leuk Lymphoma; 1995 Mar; 17(1-2):127-33. PubMed ID: 7773149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excessive production of transforming growth factor-beta by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production.
    Lagneaux L; Delforge A; Dorval C; Bron D; Stryckmans P
    Blood; 1993 Oct; 82(8):2379-85. PubMed ID: 7691258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines released in vitro by stromal cells from autologous bone marrow transplant patients with lymphoid malignancy.
    Roingeard F; Binet C; Lecron JC; Truglio D; Colombat P; Domenech J
    Eur J Haematol; 1998 Aug; 61(2):100-8. PubMed ID: 9714521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low frequency of myeloid progenitor cells in chronic idiopathic neutropenia of adults may be related to increased production of TGF-beta1 by bone marrow stromal cells.
    Papadaki HA; Giouremou K; Eliopoulos GD
    Eur J Haematol; 1999 Sep; 63(3):154-62. PubMed ID: 10485270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
    Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
    Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells.
    Lagneaux L; Delforge A; Snoeck R; Stryckmans P; Bron D
    Exp Hematol; 1994 Jan; 22(1):26-30. PubMed ID: 7506672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of chemokine mRNA in bone marrow stromal cells: modulation by TGF-beta 1 and IL-4.
    Gautam SC; Noth CJ; Janakiraman N; Pindolia KR; Chapman RA
    Exp Hematol; 1995 Jun; 23(6):482-91. PubMed ID: 7768303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells.
    Lotz M; Ranheim E; Kipps TJ
    J Exp Med; 1994 Mar; 179(3):999-1004. PubMed ID: 8113691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.
    Wetzler M; Estrov Z; Talpaz M; Kim KJ; Alphonso M; Srinivasan R; Kurzrock R
    Cancer Res; 1994 Apr; 54(7):1837-42. PubMed ID: 8137298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia.
    Zaninoni A; Imperiali FG; Pasquini C; Zanella A; Barcellini W
    Exp Hematol; 2003 Mar; 31(3):185-90. PubMed ID: 12644014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential inhibitory effect of soluble factor(s) in human bone marrow stromal cells on proliferation of K562 leukemia cells versus normal myeloid progenitor cells.
    Aoyagi A; Aoyagi M; Waga K; Enokihara H; Furusawa S
    Int J Hematol; 1996 Apr; 63(3):205-13. PubMed ID: 8936334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection and replication of human cytomegalovirus in bone marrow stromal cells: effects on the production of IL-6, MIP-1alpha, and TGF-beta1.
    Taichman RS; Nassiri MR; Reilly MJ; Ptak RG; Emerson SG; Drach JC
    Bone Marrow Transplant; 1997 Mar; 19(5):471-80. PubMed ID: 9052914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
    Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
    Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium.
    De Bruyn C; Delforge A; Bron D; Ley P; de Hemptinne D; Stryckmans P
    Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells.
    Lagneaux L; Delforge A; Bron D; De Bruyn C; Stryckmans P
    Blood; 1998 Apr; 91(7):2387-96. PubMed ID: 9516138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of granulocyte colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor after interleukin-1 stimulation of marrow stromal cell cultures from normal or aplastic anemia donors.
    Migliaccio AR; Migliaccio G; Adamson JW; Torok-Storb B
    J Cell Physiol; 1992 Jul; 152(1):199-206. PubMed ID: 1377699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role for cyclic AMP in the postreceptor control of cytokine-stimulated stromal cell growth factor production.
    Derigs HG; Burgess GS; Klingberg D; Nahreini TS; Mochizuki DY; Williams DE; Boswell HS
    Leukemia; 1990 Jul; 4(7):471-9. PubMed ID: 2165202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive and modulated cytokine expression in two permanent human bone marrow stromal cell lines.
    Thalmeier K; Meissner P; Reisbach G; Hültner L; Mortensen BT; Brechtel A; Oostendorp RA; Dörmer P
    Exp Hematol; 1996 Jan; 24(1):1-10. PubMed ID: 8536785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of in vitro hematopoiesis in B-chronic lymphocytic leukemia by antibodies to tumor necrosis factor.
    Michalevicz R; Porat R; Vechoropoulos M; Baron S; Yanoov M; Cycowitz Z; Shibolet S
    Leuk Res; 1991; 15(2-3):111-20. PubMed ID: 2016903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia.
    Gora-Tybor J; Blonski JZ; Robak T
    Mediators Inflamm; 2003 Jun; 12(3):167-71. PubMed ID: 12857600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.